The independent source of truth for peptides.

Compound data, vendor trust scores, clinic comparisons, and FDA status tracking — built on transparency, not affiliate commissions.

FDA Update — April 15, 2026: 12 Peptides Removed from Category 2

Breaking
BPC-157Pending PCACTB-500Pending PCACSemaglutideFDA ApprovedTirzepatideFDA ApprovedSemaxPending PCACIpamorelinCategory 1View all →

Built on Independence

We don't sell peptides. We don't take vendor money to influence rankings. Our trust scores are calculated from verified COA data, independent lab results, and community reviews. Every score is transparent and auditable.

No affiliate commissions
No paid rankings
No product sales
See how we compare to other peptide information sources →

Stay Informed. Weekly Peptide Intelligence.

FDA updates, new research, vendor alerts, and market analysis — delivered every Tuesday.

No spam. Unsubscribe anytime.

What We're Building Next

TruPeptide is actively growing. Here's what's on the roadmap.

Breaking News Alerts

Automated RSS monitoring of FDA and Federal Register feeds with instant email alerts.

Live

Weekly Analytics Digest

Platform engagement stats delivered to your inbox every Sunday.

Live

PCAC Live Coverage

Real-time updates from the July 23–24 FDA advisory meeting.

July 2026

Regulatory Alert Email

Per-compound email alerts for regulatory changes. Paid tier candidate.

In development

Table Virtualization

Lazy-load compound table for 100+ rows of data.

Planned

Mobile App

Native mobile experience for compound lookup and regulatory alerts.

Exploring

Have a feature request? Let us know